Eli Lilly issues Zyprexa damage control statement

After a rather scathing report in the New York Times, it looks like the pharmaceutical giant Eli Lilly is in hot water yet again. Lilly’s own published data, which it told its sales representatives to play down in conversations with doctors, has shown that 30 percent of patients taking Zyprexa gain 22 pounds or more … Continue reading Eli Lilly issues Zyprexa damage control statement